The Food and Drug Administration is moving at “lightning speed” to review data on Gilead Sciences Inc.’s experimental Covid-19 treatment remdesivir, Commissioner Stephen Hahn said, after encouraging results emerged from a key U.S. trial.
FDA moving at ‘lightning speed’ on Gilead drug, commissioner says
More Stories
LGBTQ-inclusive books are hard to find. So these groups started sending them to schools.
At least six arrested as ‘Stop the Steal’ protesters and counter-protesters clash in Washington, DC
Two LA County sheriff’s deputies involved in the fatal shooting of Andres Guardado relieved of duties following unrelated investigation